A planning committee of the National Academies of Sciences, Engineering, and Medicine will organize and conduct a public workshop to examine how genomic data are used in health care settings and to identify opportunities for advancement of precision health care delivery. The overarching goal of the workshop is to examine strategies to ensure that genomic applications are responsibly and equitably adopted to benefit populations as well as individuals over time.
The public workshop will feature invited presentations and discussions to explore:

• Examples of how genomic data are being used to assess health risk outside of traditional settings for clinical genetics (e.g., prenatal screening and testing, newborn screening, polygenic risk scores) and guide decision-making with an eye toward understanding challenges and opportunities related to equity of access to innovation in science and population level adoption of genomic applications;
• How patients, clinicians, and payers assess and act upon the risks and benefits of genomic screening and diagnostic testing; and
• Challenges of integrating genomic data from various sources into clinical decision-making including those obtained outside of traditional clinical care settings (e.g., direct-to-consumer, consumer directed, workplace genetic testing) to support equitable precision health care.

The planning committee will organize the workshop, develop the agenda, select and invite speakers and discussants, and moderate or identify moderators for the discussions. A broad array of stakeholders may take part in the workshop, including clinicians, genomics experts, users of the health care system (e.g., patients and families), payers, bioethicists, regulators, data scientists, and policy makers. Proceedings of the presentations and discussions at the workshop will be prepared by a designated rapporteur in accordance with institutional guidelines.